Silvia Buttignol

1.1k citations
8 papers · 716 indexed · h-index 5
Topics
Multiple Myeloma Research and Treatments (5 papers)Cancer Treatment and Pharmacology (2 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers)
Partner nations
ItalyUnited States

In The Last Decade

Silvia Buttignol

8 papers receiving 703 citations

Peers

Silvia Buttignol
Comparison fields: 5 of 38
  • Hematology 657
  • Oncology 392
  • Molecular Biology 301
  • Genetics 107
  • Pathology and Forensic Medicine 87
Replace Beatrice Anna Zannetti with:
Beatrice Anna Zannetti Italy
Jeffrey Haessler United States
Nicola Lang Germany
Michela Ceccolini Italy
Christiane Heiß Germany
Maximilian Merz Germany
R. Fanin Italy
Francesca Carobolante Italy
Brian Østergaard United States
Roberto Sorasio Italy
Silvia Buttignol relative to Beatrice Anna Zannetti Italy Beatrice Anna Zannetti's profile →
Citations per field
00.5×1.5×
Beatrice Anna Zannetti · 1×
Citations per year

Countries citing papers authored by Silvia Buttignol

Since Specialization
Citations

This map shows the geographic impact of Silvia Buttignol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Buttignol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Buttignol more than expected).

Fields of papers citing papers by Silvia Buttignol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Buttignol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Buttignol. The network helps show where Silvia Buttignol may publish in the future.

Co-authorship network of co-authors of Silvia Buttignol

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Buttignol. A scholar is included among the top collaborators of Silvia Buttignol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Buttignol. Silvia Buttignol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 34
2 1
3 49
4 355
5 1
6 25
7 249
8 2

About Silvia Buttignol

Silvia Buttignol is a scholar working on Hematology, Genetics and Oncology, having authored 8 papers that have together received 716 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (657 citations), Oncology (392 citations) and Genetics (107 citations). Silvia Buttignol has collaborated with scholars based in Italy and United States. Frequent co-authors include Elena Zamagni, Francesca Patriarca, Michèle Cavo, Cristina Nanni, Annamaria Brioli, Michele Baccarani, Emanuela Englaro, Giulia Perrone, Paola Tacchetti and Stefano Fanti. Their work appears in journals such as Blood, Haematologica and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026